Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase 2/3 4Phase NA 3Phase 1 2Phase 4 1Phase 3 1

Status

Completed 2Terminated 1Recruiting 1

Sponsor Class

OTHER 11INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 27Neoplasms 22Breast Neoplasms 20Neoplasm Metastasis 18Colorectal Neoplasms 16Stomach Neoplasms 15Recurrence 15Prostatic Neoplasms 15Carcinoma, Hepatocellular 12Pancreatic Neoplasms 11Ovarian Neoplasms 11Head and Neck Neoplasms 11Squamous Cell Carcinoma of Head and Neck 10Lung Neoplasms 10Myasthenia Gravis 9Melanoma 9Leukemia, Myeloid, Acute 9Urinary Bladder Neoplasms 8Lymphoma, Large B-Cell, Diffuse 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Multiple Myeloma 6Lymphoma, Non-Hodgkin 6Liver Neoplasms 6Cholangiocarcinoma 6Carcinoma, Transitional Cell 6Triple Negative Breast Neoplasms 5Small Cell Lung Carcinoma 5Lymphoma, Follicular 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Leukemia 5

Interventions

Methylphenidate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × INDUSTRY × Fatigue × Clear all
NCT06989437 2026-05-20

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Pfizer

Phase 2/3 Recruiting
982 enrolled
Gastrointestinal

Anorexia, Cachexia, Fatigue, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms, Weight Loss

NCT00518869 2025-06-04

Complementary Treatment of PG2 to Improve Clinical Benefit Response and Quality of Life in Fatigue

PhytoHealth Corporation

Phase 2/3 Terminated
13 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Fatigue

NCT00523107 2025-06-04

PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care

PhytoHealth Corporation

Phase 2/3 Completed
91 enrolled

Fatigue

NCT00758407 2010-01-13

EMF

Medice Arzneimittel Pütter GmbH & Co KG

Phase 2/3 Completed
66 enrolled

Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡